FDA.reportPublic FDA data

Samsca 30 MG Hyponatremia Oral Tablet

RxCUI
849835
RxNorm name
Samsca 30 MG Hyponatremia Oral Tablet
Display name
Samsca 30 MG Hyponatremia Oral Tablet
Full name
Samsca 30 MG Hyponatremia Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:59

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SAMSCATOLVAPTANOtsuka America Pharmaceutical, Inc.5526617c-c7b9-4556-886d-729bbabbc5662026-05-07Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 849835

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
5526617c-c7b9-4556-886d-729bbabbc566Samsca 30 MG Oral Tablet [PSN] · Hyponatremia tolvaptan 30 MG Oral Tablet [Samsca] [SBD] · Hyponatremia Samsca 30 MG Oral Tablet [SY] · Samsca 30 MG Hyponatremia Oral Tablet [SY]423These highlights do not include all the information needed to use SAMSCA safely and effectively. See full prescribing information for SAMSCA. SAMSCA ® (tolvaptan) tablets, for oral use Initial U.S. Approval: 200920260507